DOI: https://dx.doi.org/10.18565/urology.2021.6.51-56
Т.В. Шатылко, С.И. Гамидов, В.М. Попков, А.Ю. Королев, Н.Г. Гасанов
1) ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. академика В. И. Кулакова» Министерства здравоохранения РФ, Москва, Россия; 2) Саратовский государственный медицинский университет им. В. И. Разумовского, Саратов, Россия
1. Gupta K., Hooton T.M., Naber K.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103–120. 2. Schito G.C., Naber K.G., Botto H., et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34(5):407–413. 3. Gupta K., Scholes D., Stamm W.E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281(8):736–738. 4. Goossens H., Ferech M., Vander Stichele R., Elseviers M. for the ESAC Project Group Outpatient antibiotic use in Europe and its association with resistance: a cross-national database study. Lancet. 2005;365:579–587. 5. Costelloe C., Metcalfe C., Lovering A., Mant D., Hay A.D. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2906. 6. EAU Guidelines: Urological Infections 7. Clinical guidelines of the Ministry of Health of the Russian Federation. RF №14 «Tsistit u zhenshchin» 2020 g. https://cr.minzdrav.gov.ru/recommend/14_2 Dostup ot 11.10.2021. Клинические рекомендации Министерства Здравоохранения РФ №14 «Цистит у женщин» 2020 г. https://cr.minzdrav.gov.ru/recommend/14_2 Доступ от 11.10.2021 8. Naber K.G. Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia. Res Rep Urol. 2013;5:39–46. 9. Nausch B. et al. The standardized herbal combination BNO 2103 contained in Canephron® N alleviates inflammatory pain in experimental cystitis and prostatitis. Phytomedicine. 2019;60:152987. 10. Martynyuk L.P., Martynyuk Lar.P., Ruzhitskaya O.A. et al. The effect of the herbal preparation Canephron® N on the diabetic nephropathy in patients with type 2 diabetes mellitus: results of a comparative cohort study. Pochki 2015;1(11):24-32. Russian (Мартынюк Л.П., Мартынюк Лар.П., Ружицкая О.А., и соавт. Влияние растительного препарата Канефрон® H на течение диабетической нефропатии у пациентов с сахарным диабетом 2-го типа: результаты сравнительного когортного исследования. Почки 2015;1(11):24–32). 11. Lokshin K. L. Comparative efficacy of standard antibiotic therapy and therapy with Canephron N for asymptomatic bacteriuria in pregnant women. Urologiia 2018;3:54-57. Russian (Локшин К.Л. Сравнительная эффективность стандартной антибиотикотерапии и терапии препаратом Канефрон Н бессимптомной бактериурии у беременных. УРОЛОГИЯ 2018;3:54–57). Doi: https://dx.doi.org/10.18565/urology.2018.3.54–57 12. Davidov M.I., Bunova N.Ye. Comparative evaluation of monotherapy with Canephron N and ciprofloxacin for acute uncomplicated cystitis in women. Urologiia. 2018;4:24-32. Russian (Давидов М.И., Бунова Н.Е. Сравнительная оценка монотерапии препаратами Канефрон Н и ципрофлоксацин острого неосложненного цистита у женщин. Урология. 2018;4:24–32). Doi: https://dx.doi.org/10.18565/urology.2018.4.24-32 13. Wagenlehner F.M., Abramov-Sommariva D., Höller M., Steindl H., Naber K.G. Non-antibiotic herbal therapy (BNO 1045) versus antibiotic therapy (fosfomycin trometamol) for the treatment of acute lower uncomplicated urinary tract infections in women: a double-blind, parallel-group, randomized, multicentre, non-inferiority phase III trial. Urol Int. 2018;101(3):327–336. 14. Ostrovsky D.A., Ehrlich A. Canephron® N (BNO 1045) may be Non-inferior to Single-dose Fosfomycin in Reducing the Need for Additional Antibiotics to Treat Women with Presumptive Uncomplicated Urinary Tract Infections. Explore (NY). 2019;15(2):165–167. 15. Stange R. et al. Results of a randomized, prospective, double-dummy, doubleblind trial to compare efficacy and safety of a herbal combination containing Tropaeoli majoris herba and Armoraciae rusticanae radix with co-trimoxazole in patients with acute and uncomplicated cystitis. Res Rep Urol. 2017;9:43–50. 16. Kulchavenya E. Acute uncomplicated cystitis: is antibiotic unavoidable? Ther Adv Urol. 2018;10(9):257–262. 17. Wawrysiuk S. et al. Prevention and treatment of uncomplicated lower urinary tract infections in the era of increasing antimicrobial resistance-non-antibiotic approaches: a systemic review. Arch. Gynecol. Obstet. 2019;300(4):821–828. 18. Alidzhanov ZH.F., Abdufattayev U.A., Makhmudov A.T. et al. Development and clinical trial of the Russian-language version of the symptoms score for acute cystitis – ACSS. Urology. 2014;6:14-22. Russian (Алиджанов Ж.Ф., Абдуфаттаев У.А., Махмудов А.Т. и др. Разработка и клиническое испытание русскоязычной версии шкалы оценки симптомов острого цистита – ACSS. Урология. 2014;6:14–22). 19. Alidjanov J.F., Abdufattaev U.A., Makhsudov S.A., et al. New self-reporting questionnaire to assess urinary tract infections and differential diagnosis: acute cystitis symptom score. Urol Int. 2014;92(2):230–236. 20. Marcon J. et al. In vitro efficacy of phytotherapeutics suggested for prevention and therapy of urinary tract infections. Infection. 2019;47(6):937–944. 21. Sinyakova L.A., Bernikov Ye.V., Loran O.B. The functional state of the kidneys in patients with purulent pyelonephritis. Vestnik urologii. 2018;6(4):49-59. Russian (Синякова Л.А., Берников Е.В., Лоран О.Б. Функциональное состояние почек у больных, перенесших гнойный пиелонефрит. Вестник урологии. 2018;6(4):49–59). 22. Grigoryan Z.G., Lokshin K.L. Use of the drug Kanefron® N in urological practice. RMZH. 2013;21(18):924-929. Russian (Григорян З.Г., Локшин К.Л. Применение препарата Канефрон® Н в урологической практике. РМЖ. 2013;21(18):924–929).
А в т о р д л я с в я з и: Т. В. Шатылко – к.м.н., врач отделения андрологии и урологии ФГБУ «НМИЦ АГиП им. академика В.И. Кулакова» МЗ РФ, Москва, Россия, e-mail: dialectic.law@gmail.com